Cargando…
Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study
To evaluate differences in macular and optic disc circulation in patients affected by Wolfram Syndrome (WS) employing optical coherence tomography-angiography (OCTA) imaging. In this retrospective study, 18 eyes from 10 WS patients, 16 eyes of 8 patients affected by type I diabetes and 17 eyes from...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825854/ https://www.ncbi.nlm.nih.gov/pubmed/35136185 http://dx.doi.org/10.1038/s41598-022-06150-6 |
_version_ | 1784647322932609024 |
---|---|
author | Battista, Marco Cascavilla, Maria Lucia Grosso, Domenico Borrelli, Enrico Frontino, Giulio Amore, Giulia Carbonelli, Michele Bonfanti, Riccardo Rigamonti, Andrea Barresi, Costanza Viganò, Chiara Tombolini, Beatrice Crepaldi, Anna Montemagni, Marina La Morgia, Chiara Bandello, Francesco Barboni, Piero |
author_facet | Battista, Marco Cascavilla, Maria Lucia Grosso, Domenico Borrelli, Enrico Frontino, Giulio Amore, Giulia Carbonelli, Michele Bonfanti, Riccardo Rigamonti, Andrea Barresi, Costanza Viganò, Chiara Tombolini, Beatrice Crepaldi, Anna Montemagni, Marina La Morgia, Chiara Bandello, Francesco Barboni, Piero |
author_sort | Battista, Marco |
collection | PubMed |
description | To evaluate differences in macular and optic disc circulation in patients affected by Wolfram Syndrome (WS) employing optical coherence tomography-angiography (OCTA) imaging. In this retrospective study, 18 eyes from 10 WS patients, 16 eyes of 8 patients affected by type I diabetes and 17 eyes from 17 healthy controls were enrolled. All patients were imaged through OCT and OCTA and vascular parameters, as perfusion density (PD) and vessel length density (VLD) were measured. OCTA showed reduced PD in WS patients at the macular superficial capillary plexus (SCP, 27.8 ± 5.3%), deep vascular complex (DVC, 33.2 ± 1.9%) and optic nerve head (ONH, 21.2 ± 9.1%) compared to both diabetic patients (SCP 33.9 ± 1.9%, P < 0.0001; DVC 33.2 ± 0.7%, P = 1.0; ONH 33.9 ± 1.3, P < 0.0001) and healthy controls (SCP 31.6 ± 2.5, P = 0.002; DVC 34.0 ± 0.7%, P = 0.089; ONH 34.6 ± 0.8%, P < 0.0001). Similarly, VLD was lower in WS patients at the SCP (10.9 ± 2.7%) and ONH levels (7.5 ± 4.1%) compared to diabetic patients (SCP 13.8 ± 1.2%, P = 0.001; DVC 13.8 ± 0.2%, P < 0.0001; ONH 13.0 ± 0.7%, P = < 0.0001), but higher in DVC (15.7 ± 1.2%, P < 0.0001). Furthermore, VLD was lower in WS patients in all the vascular parameters compared to controls (SCP 13.8 ± 1.5%, P < 0.0001; DVC 17.3 ± 0.6%, P < 0.0001; ONH 15.7 ± 0.5%, P < 0.0001). A significant microvasculature impairment in the macular SCP and ONH microvasculature was demonstrated in eyes affected by WS. Microvascular impairment may be considered a fundamental component of the neurodegenerative changes in WS. |
format | Online Article Text |
id | pubmed-8825854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88258542022-02-09 Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study Battista, Marco Cascavilla, Maria Lucia Grosso, Domenico Borrelli, Enrico Frontino, Giulio Amore, Giulia Carbonelli, Michele Bonfanti, Riccardo Rigamonti, Andrea Barresi, Costanza Viganò, Chiara Tombolini, Beatrice Crepaldi, Anna Montemagni, Marina La Morgia, Chiara Bandello, Francesco Barboni, Piero Sci Rep Article To evaluate differences in macular and optic disc circulation in patients affected by Wolfram Syndrome (WS) employing optical coherence tomography-angiography (OCTA) imaging. In this retrospective study, 18 eyes from 10 WS patients, 16 eyes of 8 patients affected by type I diabetes and 17 eyes from 17 healthy controls were enrolled. All patients were imaged through OCT and OCTA and vascular parameters, as perfusion density (PD) and vessel length density (VLD) were measured. OCTA showed reduced PD in WS patients at the macular superficial capillary plexus (SCP, 27.8 ± 5.3%), deep vascular complex (DVC, 33.2 ± 1.9%) and optic nerve head (ONH, 21.2 ± 9.1%) compared to both diabetic patients (SCP 33.9 ± 1.9%, P < 0.0001; DVC 33.2 ± 0.7%, P = 1.0; ONH 33.9 ± 1.3, P < 0.0001) and healthy controls (SCP 31.6 ± 2.5, P = 0.002; DVC 34.0 ± 0.7%, P = 0.089; ONH 34.6 ± 0.8%, P < 0.0001). Similarly, VLD was lower in WS patients at the SCP (10.9 ± 2.7%) and ONH levels (7.5 ± 4.1%) compared to diabetic patients (SCP 13.8 ± 1.2%, P = 0.001; DVC 13.8 ± 0.2%, P < 0.0001; ONH 13.0 ± 0.7%, P = < 0.0001), but higher in DVC (15.7 ± 1.2%, P < 0.0001). Furthermore, VLD was lower in WS patients in all the vascular parameters compared to controls (SCP 13.8 ± 1.5%, P < 0.0001; DVC 17.3 ± 0.6%, P < 0.0001; ONH 15.7 ± 0.5%, P < 0.0001). A significant microvasculature impairment in the macular SCP and ONH microvasculature was demonstrated in eyes affected by WS. Microvascular impairment may be considered a fundamental component of the neurodegenerative changes in WS. Nature Publishing Group UK 2022-02-08 /pmc/articles/PMC8825854/ /pubmed/35136185 http://dx.doi.org/10.1038/s41598-022-06150-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Battista, Marco Cascavilla, Maria Lucia Grosso, Domenico Borrelli, Enrico Frontino, Giulio Amore, Giulia Carbonelli, Michele Bonfanti, Riccardo Rigamonti, Andrea Barresi, Costanza Viganò, Chiara Tombolini, Beatrice Crepaldi, Anna Montemagni, Marina La Morgia, Chiara Bandello, Francesco Barboni, Piero Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study |
title | Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study |
title_full | Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study |
title_fullStr | Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study |
title_full_unstemmed | Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study |
title_short | Retinal vascular impairment in Wolfram syndrome: an optical coherence tomography angiography study |
title_sort | retinal vascular impairment in wolfram syndrome: an optical coherence tomography angiography study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825854/ https://www.ncbi.nlm.nih.gov/pubmed/35136185 http://dx.doi.org/10.1038/s41598-022-06150-6 |
work_keys_str_mv | AT battistamarco retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT cascavillamarialucia retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT grossodomenico retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT borrellienrico retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT frontinogiulio retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT amoregiulia retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT carbonellimichele retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT bonfantiriccardo retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT rigamontiandrea retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT barresicostanza retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT viganochiara retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT tombolinibeatrice retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT crepaldianna retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT montemagnimarina retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT lamorgiachiara retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT bandellofrancesco retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy AT barbonipiero retinalvascularimpairmentinwolframsyndromeanopticalcoherencetomographyangiographystudy |